Cancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapy.
To determine whether resistance to chemoimmunotherapy is acquired during therapy, we investigated the effects of chemotherapeutic agents and anti-tumour polysaccharide, lentinan, on the progression of Rous sarcoma virus-induced S908.D2 fibrosarcomas. The chemoimmunotherapy was effective against the...
Main Authors: | Hamuro, J., Kikuchi, T., Takatsuki, F., Suzuki, M. |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
1996
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074464/ |
Similar Items
-
Chemoimmunotherapy as long-term maintenance therapy for cancer
by: Egilmez, Nejat K., et al.
Published: (2012) -
Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide
by: Malvicini, Mariana, et al.
Published: (2012) -
Delay Differential Model for Tumour-Immune Response with Chemoimmunotherapy and Optimal Control
by: Rihan, F. A., et al.
Published: (2014) -
Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.
by: Mulder, N. H., et al.
Published: (1994) -
Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy
by: Heo, Min Beom, et al.
Published: (2015)